We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of a Ultra-sound of the Lung to Diagnose Lung Diseases

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01225367
First Posted: October 21, 2010
Last Update Posted: August 13, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Echosense Ltd.
October 19, 2010
October 21, 2010
August 13, 2015
August 2010
May 2015   (Final data collection date for primary outcome measure)
Diagnose specific pattern of LDS signals as Power and Velocity in pulmonary diseases in comparison to controls. [ Time Frame: 1 year ]
Not Provided
Complete list of historical versions of study NCT01225367 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Use of a Ultra-sound of the Lung to Diagnose Lung Diseases
Detection and Characterization of Cardio-pulmonary Patho-physiological States and Diseases by Ultrasound Transthoracic Doppler

The study is a prospective open evaluating study of Ultrasound/Doppler application to the chest cavity intended to detect and characterize pathologies of the pulmonary and cardio-vascular system.

The system is a noninvasive non-imaging device designated to monitor flow and movement velocity and display the data continuously.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
primary care clinic
  • Pulmonary Pathologies
  • Cardio-pulmonary Diseases
Device: ultrasound doppler monitoring
Regular noninvasive chest echo monitoring
pulmonary doppler
Intervention: Device: ultrasound doppler monitoring
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
120
August 2015
May 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18y or older
  • patients who are clinically suspected of having a significant pulmonary or cardio-pulmonary disease
  • Patients with CHF
  • Patients with pulmonary hypertension
  • Patients with COPD
  • Patients with Asthma
  • Signed informed consent
  • Normal subjects

Exclusion Criteria:

  • Patients with unstable conditions: unstable angina, uncontrolled CHF, etc
  • Inability to assume a sitting or supine position
  • Patients with severe chest wall deformity
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT01225367
ES_DOP05
No
Not Provided
Not Provided
Echosense Ltd.
Echosense Ltd.
Not Provided
Principal Investigator: Moshe Person, MD Elisha Hospital
Echosense Ltd.
May 2011